Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gooley

Showing results (701-710 of 889) with videos related to

Pageof 89
Sort By:
Blood Neoplasia|June 19, 2025
Phase 1 trial of venetoclax with cladribine, cytarabine, G-CSF, and mitoxantrone for AML and high-grade myeloid neoplasmSuravi Raychaudhuri, Ted A Gooley, Allegra Rasmussen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 1998
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's diseaseK Schiffman, C D Buckner, R Maziarz, et al.
Clinical Kidney Journal|November 11, 2024
Bidirectional association of sleep disorders with chronic kidney disease: a systematic review and meta-analysisJin Hean Koh, Claire Yi Jia Lim, Kvan Jie Ming Yam, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Mapping MHC-resident transplantation determinantsMari Malkki, Ted A Gooley, Mary M Horowitz, et al.
Blood|January 7, 1998
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host diseaseJ Storek, T Gooley, M Siadak, et al.
British Journal of Haematology|April 10, 2015
A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of ageSarah A Buckley, Raya Mawad, Ted A Gooley, et al.
British Journal of Haematology|January 25, 2003
Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remissionLyle C Feinstein, Brenda M Sandmaier, Ute Hegenbart, et al.
Sleep Health|December 21, 2019
Antenatal sleep quality associated with perinatal outcomes in women of advanced maternal agePei Yu Lee, Li Hui Liu, Cowan Ho, et al.
Plos Pathogens|July 8, 2021
Definition of the immune evasion-replication interface of rabies virus P proteinJingyu Zhan, Angela R Harrison, Stephanie Portelli, et al.
Transplantation and Cellular Therapy|March 9, 2026
Tooth loss and oral health-related quality of life in a sub-cohort within the Chronic Graft-versus-Host Disease ConsortiumNathaniel S Treister, Lang Liang, Stephanie J Lee, et al.
Pageof 89

Showing results (701-710 of 889) with videos related to

Sort By:
Pageof 89
Blood Neoplasia|June 19, 2025
Phase 1 trial of venetoclax with cladribine, cytarabine, G-CSF, and mitoxantrone for AML and high-grade myeloid neoplasmSuravi Raychaudhuri, Ted A Gooley, Allegra Rasmussen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 1998
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's diseaseK Schiffman, C D Buckner, R Maziarz, et al.
Clinical Kidney Journal|November 11, 2024
Bidirectional association of sleep disorders with chronic kidney disease: a systematic review and meta-analysisJin Hean Koh, Claire Yi Jia Lim, Kvan Jie Ming Yam, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Mapping MHC-resident transplantation determinantsMari Malkki, Ted A Gooley, Mary M Horowitz, et al.
Blood|January 7, 1998
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host diseaseJ Storek, T Gooley, M Siadak, et al.
British Journal of Haematology|April 10, 2015
A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of ageSarah A Buckley, Raya Mawad, Ted A Gooley, et al.
British Journal of Haematology|January 25, 2003
Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remissionLyle C Feinstein, Brenda M Sandmaier, Ute Hegenbart, et al.
Sleep Health|December 21, 2019
Antenatal sleep quality associated with perinatal outcomes in women of advanced maternal agePei Yu Lee, Li Hui Liu, Cowan Ho, et al.
Plos Pathogens|July 8, 2021
Definition of the immune evasion-replication interface of rabies virus P proteinJingyu Zhan, Angela R Harrison, Stephanie Portelli, et al.
Transplantation and Cellular Therapy|March 9, 2026
Tooth loss and oral health-related quality of life in a sub-cohort within the Chronic Graft-versus-Host Disease ConsortiumNathaniel S Treister, Lang Liang, Stephanie J Lee, et al.
Pageof 89